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Background and aims: Cocoa flavanols are recognized by their favourable antioxidant 
and vascular effects. This study investigates the influence on health of the daily 
consumption of ready-to-eat meals supplemented with cocoa extract within a 
hypocaloric diet, on middle-aged overweight/obese subjects.  
Methods and results: Fifty healthy male and female middle-aged volunteers 
[57.26±5.24 years and body mass index (BMI) 30.59±2.33 kg/m2] were recruited to 
participate in a 4 week randomised, parallel and double-blind study. After following 3 
days on a low-polyphenol diet, 25 volunteers received meals supplemented with 1.4g of 
cocoa extract (645.3mg of polyphenols) and the other 25 participants received control 
meals, within a 15% energy restriction diet. On the 4th week of intervention individuals 
in both dietary groups improved (p<0.05) anthropometric, body composition, blood 
pressure and blood biochemical measurements. Oxidized LDL cholesterol (oxLDL), 
showed a higher reduction (p=0.030) in the cocoa group. Moreover, myeloperoxidase 
(MPO) levels decreased only in the cocoa supplemented group (p=0.007). Intercellular 
Adhesion Molecule-1 (sICAM-1) decreased significantly in both groups, while 
Vascular Cell Adhesion Molecule-1 (sVCAM-1) did not present differences after the 4 
weeks of intervention.  Interestingly, cocoa intake showed a different effect by gender, 
presenting more beneficial effects in men.  
Conclusions: The consumption of cocoa extract as part of ready-to-eat meals and 
within a hypocaloric diet improved oxidative status (oxLDL) in middle-aged subjects, 
being most remarkable in males. 




Obesity and overweight status are associated with the risk of suffering from chronic 
diseases such as cardiovascular disease or atherosclerosis (1). Middle-aged and elderly 
population is growing up in developed countries due to the increase of life expectancy. 
However, the prevalence of obesity and chronic diseases is high in these age groups (2). 
Moreover, changes in cardiovascular physiology with aging and the presence of 
comorbidities, make atherosclerotic complications the leading cause of death in these 
countries (2). 
Oxidative stress is a process directly implicated in atherosclerosis, and therefore 
associated with the development of cardiovascular diseases (3).  Despite the presence of 
an antioxidant system in the human organism, the imbalance created when antioxidant 
system is weak and the production of reactive oxygen species is increased, favours the 
establishment of a harmful oxidative stress situation (4). Moreover, antioxidant status 
tends to be unfavourable with age (5), and it seems that the antioxidant protection is 
lower in men than in women (6).   
Some foods consumed in human diet, contain natural bioactive compounds with 
antioxidant properties, such as plant derived polyphenols whose consumption provides 
protection against oxidative stress and apparently prevents the incidence of 
cardiovascular events (7).  
In this context, cocoa bean is one of the richest dietary source of flavanols, a type of 
polyphenols with recognized potential health effects (8). Several studies have observed 
a strong link between their consumption and a decrease of blood pressure (BP) levels 
(9). Moreover, cocoa flavanols can influence blood lipid levels by decreasing low-
density lipoprotein-cholesterol (LDL-c), increasing high-density lipoprotein-cholesterol 
(HDL-c) and inhibiting oxidized LDL-c production (oxLDL), which is one of the most 
important triggers implicated in atherosclerosis (10, 11). Furthermore, cocoa polyphenol 
intake has a positive effect on inflammation, insulin resistance and endothelial function 
(12, 13). 
Given the increasing availability of ready-to-eat meals and the potential beneficial 
effects of cocoa flavanols on human health, the objective of this trial was to assess the 
influence on oxidative status blood glucose and lipid profile of the daily consumption of 
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ready-to-eat meals supplemented with cocoa extract within a hypocaloric diet on 
middle-aged overweight/obese subjects. Moreover, we analysed whether the effect of 
cocoa consumption on oxidative status depends on gender. 
METHODS 
Study population 
The volunteers, 50 healthy Caucasian (23 men and 27 women) with 57.26 ± 5.24 year 
and with BMI of 30.59 ± 2.33 kg/m2 were recruited between March and May of 2012, 
by advertisements in local newspapers. The study was carried out in the Metabolic Unit 
of the University of Navarra (Spain). The participants gave written informed consent to 
participate in the trial. The inclusion criteria were age (50-80 years), BMI (27.0-35.5 
kg/m2) and to maintain a stable weight (<5% of variation) the previous three months to 
the intervention. The exclusion criteria were history of  metabolic disorders, 
gastrointestinal diseases, diabetes, cancer, inflammatory diseases (such as rheumatoid 
arthritis), food allergies, cognitive alterations, current sliming, hormone replacement, 
anti-inflammatory or BP lowering treatments, medication that could influence appetite 
or nutrient absorption, inability to perform the follow-up and being smoker. The study 
was approved by the Research Ethics Committee of the University of Navarra (ref. no 
006/2012) and followed the Helsinki Declaration guidelines. The trial was registered at 
www.clinicaltrials.gov (NCT01596309) on 9th may 2012. 
Study design and diet monitoring 
The study was designed as a 4 week double-blind, randomised, placebo-controlled 
parallel nutritional intervention. One week before the beginning of the study the 
volunteers had to exclude cocoa and cocoa containing products from their habitual diet 
and three days prior to the start of the trial were asked to consume a low-polyphenol 
diet without energy restriction. After these previous preparatory days, volunteers were 
provided every week with ready-to-eat meals, which were weekly supplied by Tutti 
Pasta S.A (Navarra, Spain). From 50 allocated volunteers, 25 subjects received meals 
supplemented with 1.4 g/d cocoa extract and 25 volunteers received control meals (the 
composition of cocoa extract is shown in Table 1). The randomisation was performed 
using the ‘‘random between 1 and 2’’ function in the Microsoft Office Excel (Microsoft 
Iberica, Spain). Boxes in which the meals were provided had the same appearance and 
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differed only on the code label, ensuring the double-blind. Those meals were consumed 
within a hypocaloric diet with an energy restriction of 15%. Resting metabolic rate was 
calculated by the Harris-Benedict equation applying the corresponding individualized 
physical activity factor, which was calculated as average daily exercise (14). The 
macronutrient distribution of the diet was 45% of total caloric value from 
carbohydrates, <30% from lipids and 22-25% from proteins. The volunteers were asked 
to exclude cocoa containing foods and polyphenol rich foods maintaining their habitual 
physical activity during the intervention. At the beginning and end of the study, a 3-day 
validated food-recall questionnaire was used to assess nutrient intake, which was 
analysed using the DIAL software (Alce Ingenieria S.L, Madrid, Spain). To evaluate the 
adherence to meal consumption, volunteers had to fill a notebook with the name of the 
dish and dessert that they consumed daily.  
Total polyphenol content and characterization of the cocoa extract 
Cocoa extract and analytical characterization were provided by Nutrafur S.A (Murcia, Spain). 
Total polyphenol content was determined by the Folin-Ciocalteu colorimetric method. Briefly, 
50 mg of cocoa extract was mixed with 100 mL of water for soluble extracts or 4 mL of 
ethanol+96ml of water for insoluble extracts. Then they were shaken during 15 minutes and 
filtered. Absorbance was measured at 765 nm. The total polyphenol content was calculated from 
the calibration curve (1ppm-8ppm) using catechin hydrate (Sigma-Aldrich C1788) as a standard 
value and expressed as milligrams of catechin per 1.4 g.  
HPLC was used to quantify the flavonoids and theobromine in the cocoa extract. For that, the 
extract was dissolved in dimethylsulfoxide (DMSO) 5 mg/mL. This solution was filtered 
through a 0.45 mm nylon membrane. The HPLC equipment used was a Hewlett-Packard Series 
HP 1100 equipped with a diode array detector. The stationary phase was a C18 LiChrospher 
100 analytical column (250 x 4 mm i.d.) with a particle size of 5 mm (Merck, Darmstadt, 
Germany) thermostated at 30ºC. The flow rate was 1 mL/min and the absorbance changes were 
monitored at 280 nm. The mobile phases for chromatographic analysis were: (A) acetic 
acid/water (1:99) and (B) acetonitrile. A linear gradient was run from 96 % (A) and 4 % (B) to 
90 % (A) during 25 min; changed to 87 % (A) in 5 min (30 min, total time); in 5 min changed to 
50 % (A) (35 min, total time), after equilibrate in for 10 min. Phenolic compounds in Cocoa 
extract were identified by comparison of their retention time with the correspondence standard 




 Anthropometric, body composition and blood pressure  
At baseline and at the end of the dietary intervention, anthropometric, body composition 
and blood pressure measurements were performed. The measurements of weight, 
height, waist circumference and body composition were taken in underwear after an 
overnight fast as described elsewhere (15). BP was taken 3 times with automatic 
monitor (Intelli Sense. M6, OMRON Healthcare, Hoofddorp, Netherlands), to use the 
average value obtained from the last two measurements. 
Blood biochemical analysis 
Fasting (10 h) blood samples were collected between 8:00-9:30 a.m at baseline and at 
the end of the intervention using EDTA and CLOT tubes. After, samples were left for 
10-15 minutes at room temperature. The, tubes were centrifuged to obtain plasma and 
serum aliquots (15 minutes, 1 500g, 4ºC), were stored at -80ºC until analysis. Plasma 
glucose, total cholesterol, HDL-c, triglycerides (TG) and proteins were measured by 
colorimetry in an auto-analyser Pentra C200 (Horiba Medical, Montpellier, France). 
LDL-c was calculated using Friedewald equation.  Plasma insulin, oxLDL, MPO 
(Mercodia, Upssala, Sweden), sVCAM-1 and sICAM-1(R&D Systems, Minneapolis, 
USA) were quantified with specific ELISA kits in a Triturus auto-analyser (Grifols, 
Barcelona, Spain).  
Statistical analysis  
Considering oxLDL as the main variable, the sample size was estimated taking into 
account a reduction of 14.1 U/L and an interquartile range of 16.3 U/L, according to the 
study carried out by Khan et al (11).With a bilateral confidence index of 95% (α=0.05) 
and a statistical power of 80% (β=0.80) the sample size was estimated in 44 subjects. 
Considering a possible drop-out rate of 15%, the final sample size was established in 50 
subjects. Normality of the variables was assessed using Shapiro-Wilk test. Data are 
expressed as mean (SD) for normally distributed variables or as median and 
interquartile range for non-normally distributed. Comparisons between baseline and end 
point, and between studies groups were accordingly analysed by Student paired t-test, 
Wilcoxon test, independent t-test or U Mann-Whitney, depending on the normality of 
the variables. Spearman correlation tests were applied to evaluate the relationship 
between changes (Δ) on oxLDL, total cholesterol, and glucose levels. Multiple linear 
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regression analysis was used to assess the effect of cocoa supplementation over %Δ 
oxLDL adjusting for different models, in which the independent variables were weight, 
total cholesterol and LDL-c, differently combined. p <0.05 was considered significant. 
The software used was SPSS 15.1 for Windows (SPSS Inc, Chicago, USA). 
RESULTS  
Participants and adherence to diet and meal consumption  
From the initial 488 subjects who contacted with the Metabolic Unit, 113 met the 
inclusion criteria and 50 subjects were randomised. Finally 47 volunteers completed the 
intervention, 24 subjects in control group and 23 in cocoa group (Figure 1). After 4 
weeks of intervention, both groups reported similar adherence to meal consumption 
(98.4 (2.2) % control and 98.5 (3.3) % cocoa group) and the dietary records showed that 
there were no significant differences between groups in macronutrient and calorie intake 
(data not shown). None of the volunteers reported side effects, taste dislike or changes 
in physical activity during the study. Moreover, there were no statistical differences at 
baseline in any of the assessed variables between groups.  
Anthropometric, body composition, blood pressure and blood biochemical 
parameters after 4 weeks of intervention 
Subjects in both dietary interventions significantly improved BP, anthropometric and 
body composition variables. Interestingly, lean mass percentage increased significantly 
in both groups (Table 2). Also, concentrations of total cholesterol, LDL-c, HDL-c, TG, 
total proteins and insulin significantly decreased (Table 2). However, no changes were 
observed in blood glucose levels (Table 2). 
oxLDL, MPO, sVCAM-1 and sICAM-1 after 4 weeks of intervention 
After 4 weeks of intervention, oxLDL concentration decreased significantly (p<0.001) 
in both groups, showing higher reduction in cocoa group (p=0.030) as it is shown in Fig 
2. . Moreover, ΔoxLDL was positively correlated with Δtotal cholesterol (rho=0.574; 
p<0.001) and Δglucose (rho=0.297; p=0.043). MPO levels decreased significantly only 
in cocoa supplemented subjects (p=0.007), without observing differences with control 
group.  Concerning sICAM-1, a significant decrease in both arms was observed, while 
no changes were found in sVCAM-1 (Table 2). 
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Considering that the literature reports poorer antioxidant status in men than in women, 
Table 3 shows the effect of cocoa consumption by gender on %ΔoxLDL. Different 
multiple linear regression models (model 1, 2 and 3) were obtained. %Δweight was 
included as independent variable because it could have an effect on %ΔoxLDL, and  
%Δtotal cholesterol and %ΔLDL-c were included due to the correlations found between 
them.  The lineal regression analysis showed a significant effect of dietary group on 
%ΔoxLDL with model 2 and 3 in men. Moreover, model 1, 2 and 3 were significant 
only in men. The 2nd model was the best to predict the variability of %ΔoxLDL, which 
was 50.3% (p= 0.001). 
DISCUSSION 
In this study, weight, waist circumference, total fat mass and truncal fat mass of the 
participants improved after following the intervention. The improvements were 
observed in both groups, indicating that cocoa supplementation did not have additional 
effect on those variables and attributing the observed changes to the hypocaloric diet 
followed by the volunteers. Our results are in agreement with two previous studies and 
one meta-analysis, in which no changes were observed in body size and composition of 
overweight/obese subjects after the cocoa supplementation (9, 16,  17). Golomb et al 
observed a negative correlation between the frequency of dark  chocolate consumption  
and BMI (18). However that is an epidemiological study in which the population 
studied had different characteristics. The increase observed on lean mass is interesting, 
as it is generally reduced after following a hypocaloric diet, being more notable with 
ageing (19). Based on previous observations, the 22-25% of protein instead of 15% can 
be pointed out as the responsible of this positive outcome (19). 
On the other hand, no additional benefits on blood lipid and glucose profile after cocoa 
supplementation were found. Some studies have reported that cocoa flavanols may 
increase HDL-c and decrease LDL-c levels (10, 11), although these outcomes are 
controversial and there is not a consensus on these effects (17). A meta-analysis carried 
out by Shrime et al (17), suggests that HDL-c levels increase in longer term trials with 
low fat consumption, whereas LDL-c and total cholesterol decrease in short-term 
studies in patients younger than 50 years-old (17). This finding is in agreement with our 
results. On the other hand, Neufingerl et al (20) have recently observed that the frequent 
consumption of 850 mg of pure theobromine significantly increased HDL-c levels. 
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They explained that theobromine increases the concentration of apolipoprotein A-I, the 
major apolipoprotein of HDL-c. However, to consume 850 mg of theobromine, 100 g of 
dark chocolate are needed, which additionally contains saturated fats and calories. 
Moreover they did not completely control the physical activity and diet during the 
intervention, factors that may influence HDL-c levels (20). 
No significant changes of TG, total cholesterol and glucose were observed  in the meta-
analysis by Shrime et al (17). However, Hooper et al (13) suggest a possible beneficial 
effect on TG and HOMA after the daily consumption of 50-100mg of epicatechins (13),  
although no effects were evident at higher or lower doses. Our subjects consumed 
153.44 mg/d of epicatechins in the cocoa group, which could explain the absence of 
effects. Moreover, a limitation is the length of the study, which no provides information 
about long-term effects.  
Although BP decreased, no additional effect due to cocoa consumption was noted, 
which is in agreement with the meta-analysis carried out by Ried et al (21) where it is 
suggested that flavanol-rich chocolate does not reduce blood pressure below 140/80 
mmHg. However, some studies have found a reduction in BP probably associated with 
the increase of nitric oxide (NO) bioavailability after cocoa flavanols consumption (12).  
MPO and oxLDL are molecules involved in the development of oxidative stress and 
consequently in atherosclerosis (22-23). Particles of oxLDL are generated during lipid 
peroxidation, and are able to damage endothelial cells. MPO is a leukocyte-derived 
enzyme that produces reactive intermediate compounds, which plays an oxidative role 
over LDL-c, contributing to the transformation into oxLDL. Nitrite, the major oxidation 
product of NO, is the substrate of MPO and favours the production of nitrogen reactive 
species, which contribute to oxidise LDL-c (23). In our study, the decrease on oxLDL 
concentration was significantly higher in the cocoa group. This finding could be linked 
to the significant decrease of MPO levels only in cocoa group, an effect probably 
related to the capacity of cocoa flavanols to modulate oxidative reactions catalysed by 
MPO (24). On the other hand, sICAM-1 and sVCAM-1, indicators of endothelial 
dysfunction, are usually overexpressed in atherosclerotic plaque.  Although they are up-
regulated by oxLDL (25-26), we have not observed a higher reduction in cocoa group as 
a consequence of the oxLDL decrease. In this sense, Farouque et al (27) reported that 
consumption of flavanol-rich chocolate bar and beverage during 6 week did not alter the 
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concentrations of ICAM-1 and VCAM-1. However, Jung-Suk et al (28), suggested that 
flavonoids are able to inhibit the expression of sVCAM-1 and s-ICAM-1.  
The antioxidant status becomes weak with age (5), with apparent poorer antioxidant 
status in men than in women (6). In agreement with this, we have found that cocoa 
consumption, adjusted for different models, has an effect on %ΔoxLDL of men, while 
in women this result was not observed. This antioxidant effect is probably related with 
the radical scavenging capacity of cocoa flavanols, which protects cells against 
oxidative stress and endothelial dysfunction (11). Other hypothesis could be that men 
were more oxidised than women, thus, the effect of cocoa flavanalos is more effective, 
given that some studies have not observed additional benefits after intake of 
antioxidants (29).  
CONCLUSION 
This study supports that the consumption of cocoa extract as part of a ready-to-eat 
meals and within a hypocaloric diet, improve oxidative status (oxLDL) in middle-aged 
subjects, and particularly in men, supporting the antioxidant effect of cocoa flavanols. 
However, additional research is needed to better understand the role of cocoa flavanols 
in cardiovascular diseases. Thus, a long-term trial including a larger sample of men, 
could contribute to clarify these promising findings.  
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FIGURE LEGENDES 
Figure 1  Flow-chart of the intervention 
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Figure 2  Oxidized LDL (oxLDL) reduction in control and cocoa group.  
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